Cargando…

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease

BACKGROUND: Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steg, Ph. Gabriel, Ferrari, Roberto, Ford, Ian, Greenlaw, Nicola, Tardif, Jean-Claude, Tendera, Michal, Abergel, Hélène, Fox, Kim M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343045/ https://www.ncbi.nlm.nih.gov/pubmed/22570699 http://dx.doi.org/10.1371/journal.pone.0036284

Ejemplares similares

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
por: Sorbets, Emmanuel, et al.
Publicado: (2019)

Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
por: Ford, Ian, et al.
Publicado: (2020)

Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2019)

Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients
por: Kalra, Paul R., et al.
Publicado: (2014)

International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study
por: Mesnier, Jules, et al.
Publicado: (2021)

Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2018)

Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
por: Sorbets, Emmanuel, et al.
Publicado: (2020)

Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry
por: Darmon, Arthur, et al.
Publicado: (2020)

Management and clinical outcome of stable coronary artery disease in Austria: Results from 5 years of the CLARIFY registry
por: Lang, Irene M., et al.
Publicado: (2017)

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
por: Tardif, Jean-Claude, et al.
Publicado: (2009)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
por: Werdan, Karl, et al.
Publicado: (2015)

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study)
por: Glezer, Maria, et al.
Publicado: (2018)

Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers
por: Grazette, Luanda, et al.
Publicado: (2022)

Multi-vessel Coronary Vasospasm after Beta-blocker Administration
por: Tamura, Yudai, et al.
Publicado: (2018)

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
por: Ducrocq, Gregory, et al.
Publicado: (2010)

Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome
por: de Matos Soeiro, Alexandre, et al.
Publicado: (2016)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

CABG and Preoperative use of Beta-Blockers in Patients with Stable Angina are Associated with Better Cardiovascular Survival
por: Dayan, Victor, et al.
Publicado: (2018)

Increase in stable isotope ratios driven by metabolic alterations in amphipods exposed to the beta-blocker propranolol
por: Ek, Caroline, et al.
Publicado: (2019)

Predictors of Beta-Blocker Intolerance and Mortality in Patients After Acute Coronary Syndrome
por: De Stefano, Laercio Martins, et al.
Publicado: (2013)

Sexual Dysfunction and the Impact of Beta-Blockers in Young Males With Coronary Artery Disease
por: Dai, Yuxiang, et al.
Publicado: (2021)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Comparative Effectiveness of Long‐Term Maintenance Beta‐Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention
por: Lee, Myunhee, et al.
Publicado: (2023)

Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients
por: Manderbacka, Kristiina, et al.
Publicado: (2008)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
por: Cojocariu, Sabina Alexandra, et al.
Publicado: (2021)

Topical beta‐blockers in dermatologic therapy
por: Filoni, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oti56oitb4jvbt5jk9r4seoskf